Wenyu Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wenyu Huang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Carolina Mendes Pessoa
1 shared publicationJeffrey A. Sosman
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
1 shared publication- Kristen Lee
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL 60611
1 shared publication Mark E. Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
1 shared publication- Mark E. Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine , Chicago, IL 60611
1 shared publication Sunandana Chandra
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
1 shared publication
Latest Publications
- Open Access
- 6 February 2026
- Published by Elsevier in AACE Endocrinology and Diabetes
- Vol. 13 (3) , 507-511
Precipitated Adrenal Insufficiency by Osilodrostat and Fluconazole in Ectopic Adrenocorticotrophic Hormone Syndrome With a Pituitary Microadenoma and Cryptococcus Infection
- 6 February 2026
- Published by Elsevier in AACE Endocrinology and Diabetes
- Vol. 13 (3) , 507-511
Open AccessPrecipitated Adrenal Insufficiency by Osilodrostat and Fluconazole in Ectopic Adrenocorticotrophic Hormone Syndrome With a Pituitary Microadenoma and Cryptococcus Infection
- Open Access
- 11 May 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Endocrine side effects of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.
- 11 May 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14
Open AccessEndocrine side effects of immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.
- 1 March 2021
- Published by Elsevier in Seminars in Nephrology
- Vol. 41 (2) , 156-167
Prolactin and Other Pituitary Disorders in Kidney Disease
- 1 March 2021
- Published by Elsevier in Seminars in Nephrology
- Vol. 41 (2) , 156-167
Prolactin and Other Pituitary Disorders in Kidney Disease